Skip to main content
NIH funding notice RFA-RM-17-025

Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3 Clinical Trials Not Allowed)

Closed on March 2, 2018.

Posted
December 18, 2017
Close date
March 2, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,550,000 in first-year total cost, median $377,500.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 IMST-H (50)]4

Most frequent institutions

  1. CALIFORNIA INSTITUTE OF TECHNOLOGY1
  2. HARVARD UNIVERSITY1
  3. PURDUE UNIVERSITY1
  4. STANFORD UNIVERSITY1
Competing awards under RFA-RM-17-025 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018High-Throughput, Highly Multiplexed In Situ Proteomic Imaging of Human Tissues1UG3HL145600-01YIN, PENGHARVARD UNIVERSITY, MA$420,000ZRG1
2018Next-Generation Genomic Imaging Technology1UG3HL145623-01DESAI, TUSHAR JASUBHAIHARBURY, PEHR ASTANFORD UNIVERSITY, CA$380,000ZRG1
2018Novel Platform for Quantitative Subcellular Resolution Imaging of Human Tissues Using Mass Spectrometry1UG3HL145593-01LASKIN, JULIAPURDUE UNIVERSITY, IN$375,000ZRG1
2018In situ transcriptome profiling in single cells1UG3HL145609-01CAI, LONGYUAN, GUO-CHENGCALIFORNIA INSTITUTE OF TECHNOLOGY, CA$375,000ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-RM-17-025: Transformative Technology Development for the Human BioMolecular Atlas Program (UG3/UH3 Clinical Trials Not Allowed) | ScienceDex | ConductScience